Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 178
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Will vitamin D improve the health of patients with heart failure?

    We are trying to determine if supplemental vitamin D in heart failure patients will improve heart function and...

    NoAAC Longitudinal Registry of Treatment Outcomes in iSGS

    Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction...

    Backer Badge Funded